The role of pharmacogenetics in the treatment of depression and anxiety disorders.

Abstract excerpt

Although effective treatment for mood and anxiety disorders have been available for more than 40 years, 30-50% of depressed patients and 25% of patients with anxiety disorder do not respond sufficiently to first-line treatment with antidepressants. Genetic factors are supposed to play a major role in both variation of treatment response and incidence of adverse effects to medication. So far, candidate genes of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Anxiety Agents
• Share to Antidepressive Agents
• Share to Anxiety Disorders